Trial Profile
Real-world study of liraglutide (Victoza) compared with sitagliptin and exenatide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Exenatide; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jul 2013 New trial record
- 24 Jun 2013 Results were presented at the 73rd Scientific Sessions of the American Diabetes Association (ADA).